Article

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1

2021-12-05

Abstract excerpt

Broadly neutralizing antibodies (bNAbs) are promising targets for vaccination and therapy against HIV. Passive infusions of bNAbs have shown promise in clinical trials as a potential alternative for anti-retroviral therapy. A key challenge for the potential clinical application of bnAbs is the suppression of viral escape, which is more effectively achieved with a combination of bNAbs. However, identifying an optim...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a8ff2f38-282c-5b98-8ed0-23543d5e478d
DOI: 10.1101/2021.12.03.21267269

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1DOI 10.1101/2021.12.03.21267269Read

Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies <i>in vivo</i>Semantic proximity Read

Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.Semantic proximity Read

Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.Semantic proximity Read

Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies.Semantic proximity Read

HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV vectored immunotherapy in humanized miceSemantic proximity Read

Predicting the broadly neutralizing antibody susceptibility of the HIV reservoirSemantic proximity Read

Engineering HIV antibodies with enhanced breadth and potency of neutralization through multistate affinity maturationSemantic proximity Read

Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodiesSemantic proximity Read

Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictableSemantic proximity Read

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV preventionSemantic proximity Read

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C InfectionSemantic proximity Read

Diverse paths to broadly neutralizing antibody escape among HIV-1 strains.Semantic proximity Read